stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. SQZB
    stockgist
    HomeTop MoversCompaniesConcepts
    SQZB logo

    SQZ Biotechnologies Company

    SQZB
    OTC
    Healthcare
    Biotechnology
    Watertown, MA, US53 employeessqzbiotech.com
    —

    At A Glance

    1

    SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions.

    2

    Revenue is primarily driven by Collaboration (100%).

    3

    No significant events in the past 90 days.

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees53
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Collaboration100%($48M)
    Activity

    What Changed Recently

    No significant events in the past 90 days.

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    IDCNIndocan Resources Inc.————
    PHCGPure Harvest Corporate Gr...————
    EMMAEmmaus Life Sciences, Inc...————
    VPROViropro Inc.————
    VIRXVIRX————
    BITRFBiotron Limited————
    YECOYulong Eco-Materials Limi...————
    HXBMHelix BioMedix, Inc.————
    Analyst View
    Company Profile
    CIK0001604477
    ISINUS78472W1045
    CUSIP78472W104
    Phone617 758 8672
    Address200 Arsenal Yards Boulevard, Watertown, MA, 02472, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice